skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 10,371  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: List of all Versions New From Last 3 Month remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines
Material Type:
Article
Add to My Research

The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines

Arthritis research & therapy, 2024-05, Vol.26 (1), p.109-109 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-024-03338-1 ;PMID: 38802957

Full text available

2
Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics
Material Type:
Article
Add to My Research

Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics

Respiratory research, 2024-05, Vol.25 (1), p.192-192 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-024-02823-0 ;PMID: 38702687

Full text available

3
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport
Material Type:
Article
Add to My Research

ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport

Cardiovascular research, 2024-05, Vol.120 (7), p.756-768 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024 ;ISSN: 0008-6363 ;EISSN: 1755-3245 ;DOI: 10.1093/cvr/cvae068 ;PMID: 38626311

Full text available

4
Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension

European journal of pharmacology, 2024-06, Vol.973, p.176564 [Peer Reviewed Journal]

Copyright © 2024 Elsevier B.V. All rights reserved. ;EISSN: 1879-0712 ;DOI: 10.1016/j.ejphar.2024.176564 ;PMID: 38614383

Digital Resources/Online E-Resources

5
Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension

Biomedicine & pharmacotherapy, 2024-05, Vol.174, p.116505-116505, Article 116505 [Peer Reviewed Journal]

2024 The Authors ;Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2024.116505 ;PMID: 38574614

Full text available

6
Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era—results from a nationwide study
Material Type:
Article
Add to My Research

Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era—results from a nationwide study

Clinical rheumatology, 2024-06, Vol.43 (6), p.1919-1925 [Peer Reviewed Journal]

The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR). ;ISSN: 0770-3198 ;EISSN: 1434-9949 ;DOI: 10.1007/s10067-024-06961-0 ;PMID: 38676757

Digital Resources/Online E-Resources

7
Emerging therapies: Potential roles of SGLT2 inhibitors in the management of pulmonary hypertension
Material Type:
Article
Add to My Research

Emerging therapies: Potential roles of SGLT2 inhibitors in the management of pulmonary hypertension

Respiratory medicine, 2024-06, Vol.227, p.107631 [Peer Reviewed Journal]

Copyright © 2024. Published by Elsevier Ltd. ;EISSN: 1532-3064 ;DOI: 10.1016/j.rmed.2024.107631 ;PMID: 38631526

Digital Resources/Online E-Resources

8
Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'
Material Type:
Article
Add to My Research

Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'

Journal of hypertension, 2024-06, Vol.42 (6), p.961 [Peer Reviewed Journal]

EISSN: 1473-5598 ;DOI: 10.1097/HJH.0000000000003682 ;PMID: 38690899

Digital Resources/Online E-Resources

9
BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension
Material Type:
Article
Add to My Research

BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5403 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25105403 ;PMID: 38791441

Full text available

10
Correlates of Weight Gain in South Asians Living in America
Material Type:
Article
Add to My Research

Correlates of Weight Gain in South Asians Living in America

Obesity (Silver Spring, Md.), 2023-11, Vol.31, p.272-272 [Peer Reviewed Journal]

Copyright Blackwell Publishing Ltd. Nov 2023 ;ISSN: 1930-7381 ;EISSN: 1930-739X

Digital Resources/Online E-Resources

11
Obesity with Hypertension Has Greater Hypercortisolemia Prevalence than Obesity with Dysglycemia
Material Type:
Article
Add to My Research

Obesity with Hypertension Has Greater Hypercortisolemia Prevalence than Obesity with Dysglycemia

Obesity (Silver Spring, Md.), 2023-11, Vol.31, p.88-89 [Peer Reviewed Journal]

Copyright Blackwell Publishing Ltd. Nov 2023 ;ISSN: 1930-7381 ;EISSN: 1930-739X

Digital Resources/Online E-Resources

12
Heritable pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Heritable pulmonary arterial hypertension

Innere Medizin (Heidelberg, Germany), 2024-06, Vol.65 (6), p.560 [Peer Reviewed Journal]

2024. The Author(s). ;EISSN: 2731-7099 ;DOI: 10.1007/s00108-024-01718-y ;PMID: 38771375

Digital Resources/Online E-Resources

13
Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling
Material Type:
Article
Add to My Research

Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling

International immunopharmacology, 2024-05, Vol.132, p.111946 [Peer Reviewed Journal]

Copyright © 2024. Published by Elsevier B.V. ;EISSN: 1878-1705 ;DOI: 10.1016/j.intimp.2024.111946 ;PMID: 38552292

Digital Resources/Online E-Resources

14
Corrigendum: Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation
Material Type:
Article
Add to My Research

Corrigendum: Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation

The Journal of clinical investigation, 2024-05, Vol.134 (9) [Peer Reviewed Journal]

COPYRIGHT 2024 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238

Full text available

15
CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR‐509‐5p/multiple C2 and transmembrane domain containing 2 axis
Material Type:
Article
Add to My Research

CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR‐509‐5p/multiple C2 and transmembrane domain containing 2 axis

The clinical respiratory journal, 2024-05, Vol.18 (5), p.e13771-n/a [Peer Reviewed Journal]

2024 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd. ;2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-6981 ;EISSN: 1752-699X ;DOI: 10.1111/crj.13771 ;PMID: 38747117

Full text available

16
Pulmonary congestion in patients with pulmonary arterial hypertension? New insights from lung ultrasound
Material Type:
Article
Add to My Research

Pulmonary congestion in patients with pulmonary arterial hypertension? New insights from lung ultrasound

European journal of heart failure, 2024-04, Vol.26 (4), p.825 [Peer Reviewed Journal]

EISSN: 1879-0844 ;DOI: 10.1002/ejhf.3259 ;PMID: 38679850

Digital Resources/Online E-Resources

17
Retracted: Mechanism of Radix Astragali and Radix Salviae Miltiorrhizae Ameliorates Hypertensive Renal Damage
Material Type:
Article
Add to My Research

Retracted: Mechanism of Radix Astragali and Radix Salviae Miltiorrhizae Ameliorates Hypertensive Renal Damage

BioMed research international, 2024, Vol.2024, p.9848535-9848535 [Peer Reviewed Journal]

Copyright © 2024 BioMed Research International. ;Copyright © 2024 BioMed Research International. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2024 BioMed Research International. 2024 ;ISSN: 2314-6133 ;EISSN: 2314-6141 ;DOI: 10.1155/2024/9848535 ;PMID: 38549996

Full text available

18
NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension
Material Type:
Article
Add to My Research

NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension

JCI insight, 2024-04, Vol.9 (10) [Peer Reviewed Journal]

EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.164191 ;PMID: 38652537

Full text available

19
Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study
Material Type:
Article
Add to My Research

Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study

Journal of the American Heart Association, 2024-04, Vol.13 (8), p.e033847-e033847 [Peer Reviewed Journal]

EISSN: 2047-9980 ;DOI: 10.1161/JAHA.123.033847 ;PMID: 38567662

Full text available

20
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
Material Type:
Article
Add to My Research

Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era

Circulation (New York, N.Y.), 2024-05, Vol.149 (20), p.1549-1564 [Peer Reviewed Journal]

EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.063821 ;PMID: 38606558

Digital Resources/Online E-Resources

Results 1 - 20 of 10,371  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2006  (7)
  2. 2006 To 2009  (16)
  3. 2010 To 2013  (29)
  4. 2014 To 2018  (121)
  5. After 2018  (10,176)
  6. More options open sub menu

New Records 

  1. New From Last Month  (1,999)
  2. More options open sub menu

Subject 

  1. Hypertension  (8,482)
  2. Blood Pressure  (3,276)
  3. Science & Technology  (2,241)
  4. Diabetes  (2,170)
  5. Humans  (2,156)
  6. Life Sciences & Biomedicine  (2,137)
  7. Cancer  (1,605)
  8. Earnings Per Share  (1,595)
  9. Arthritis  (1,500)
  10. Institutional Investments  (1,452)
  11. Cardiovascular Disease  (1,384)
  12. Risk Factors  (1,347)
  13. Female  (1,252)
  14. Male  (1,140)
  15. Patients  (1,116)
  16. Dividends  (1,080)
  17. Pulmonary Hypertension  (1,054)
  18. Hedge Funds  (992)
  19. Wealth Management  (952)
  20. Stockholders  (886)
  21. More options open sub menu

Language 

  1. English  (10,165)
  2. Chinese  (122)
  3. French  (29)
  4. Spanish  (24)
  5. Portuguese  (20)
  6. Russian  (17)
  7. German  (14)
  8. Japanese  (5)
  9. Turkish  (4)
  10. Indonesian  (3)
  11. Korean  (3)
  12. Hungarian  (1)
  13. Italian  (1)
  14. Urdu  (1)
  15. Croatian  (1)
  16. Bulgarian  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait